Omada Health (NASDAQ: OMDA) insider eyes 300-share sale after 10b5-1 trades

Rhea-AI Filing Summary

OMDA reported insider sales in a Form 144 notice by Sean Duffy. The filing lists a 300-share transaction tied to an exercise of stock options on 06/25/2026 and two prior 10b5-1 sales: 2,800 shares on 06/24/2026 for $53,238.92 and 14,960 shares on 06/16/2026 for $259,711.58.

The transactions are presented as sales under a 10b5-1 plan and an option exercise; cash-flow treatment for the option exercise is listed as Cash.

Insights

Securities Compliance Analyst

Routine Rule 144 notice listing option exercise and 10b5-1 dispositions.

The filing lists a 300-share exercise on 06/25/2026 and two 10b5-1 sales of 2,800 and 14,960 shares on 06/24/2026 and 06/16/2026, with cash amounts documented for the 10b5-1 sales.

These entries are procedural disclosures required when restricted or control securities are sold; cash-flow treatment for the exercise is labeled Cash. Subsequent filings may show any continuing dispositions or related holdings.

Key Figures

Option exercise: 300 shares 10b5-1 sale proceeds (6/24/2026): $53,238.92 10b5-1 sale proceeds (6/16/2026): $259,711.58 +2 more

5 metrics

Option exercise 300 shares exercise of stock options on 06/25/2026; cash treatment

10b5-1 sale proceeds (6/24/2026) $53,238.92 proceeds for 2,800 shares sold on 06/24/2026

10b5-1 sale proceeds (6/16/2026) $259,711.58 proceeds for 14,960 shares sold on 06/16/2026

10b5-1 sale (6/24/2026) 2,800 shares sale reported under a 10b5-1 plan on 06/24/2026

10b5-1 sale (6/16/2026) 14,960 shares sale reported under a 10b5-1 plan on 06/16/2026

Key Terms

Form 144, 10b5-1, Exercise of Stock Options

3 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 06/25/2026 | Exercise of Stock Options"

FAQ

What sales did OMDA report in the Form 144 filed by Sean Duffy?

The Form 144 lists a 300-share option exercise sold for cash on 06/25/2026. It also records 10b5-1 sales of 2,800 shares on 06/24/2026 and 14,960 shares on 06/16/2026 with documented proceeds.

How much cash was reported for the 10b5-1 sales in the OMDA Form 144?

The filing shows proceeds of $53,238.92 for the 2,800-share sale on 06/24/2026 and $259,711.58 for the 14,960-share sale on 06/16/2026, as disclosed in the notice.

Was the 300-share transaction in the OMDA filing an exercise or an open-market sale?

The 300-share entry on 06/25/2026 is listed as an exercise of stock options with cash indicated as the treatment. The filing ties that transaction to issuer-side option exercise activity.

Do the OMDA filings state the transactions were made under a trading plan?

Yes; the Form 144 identifies the June dispositions as 10b5-1 sales, indicating they were effected under a pre-arranged trading plan, as stated in the entries for 06/24/2026 and 06/16/2026.

Does the Form 144 show who received the cash proceeds from these transactions?

The notice lists proceeds for the 10b5-1 sales as $53,238.92 and $259,711.58; the filing lists the transactions as sales by the reporting person, without additional payee allocation details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/25/2026 - 04:32 PM Accepted by SEC EDGAR 06/25/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	300	5580.00	59448507	06/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2026	Exercise of Stock Options	Issuer			300	06/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/24/2026	2800	53238.92
10b5-1 Sales for SEAN DUFFY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/16/2026	14960	259711.58

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)